Nouscom SRL
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma (NCT04990479) | Nouscom SRL | 2021-06-11 |
| Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors (NCT04041310) | Nouscom SRL | 2019-10-21 |
Track Nouscom SRL automatically
Every clearance here is in the API, with alerts when new ones post.